216 related articles for article (PubMed ID: 2536257)
1. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
Merigan TC; Skowron G; Bozzette SA; Richman D; Uttamchandani R; Fischl M; Schooley R; Hirsch M; Soo W; Pettinelli C
Ann Intern Med; 1989 Feb; 110(3):189-94. PubMed ID: 2536257
[TBL] [Abstract][Full Text] [Related]
2. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Merigan TC; Skowron G
Am J Med; 1990 May; 88(5B):11S-15S. PubMed ID: 2159703
[TBL] [Abstract][Full Text] [Related]
4. In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine.
Yarchoan R; Mitsuya H; Thomas RV; Pluda JM; Hartman NR; Perno CF; Marczyk KS; Allain JP; Johns DG; Broder S
Science; 1989 Jul; 245(4916):412-5. PubMed ID: 2502840
[TBL] [Abstract][Full Text] [Related]
5. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
[TBL] [Abstract][Full Text] [Related]
6. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
Yarchoan R; Perno CF; Thomas RV; Klecker RW; Allain JP; Wills RJ; McAtee N; Fischl MA; Dubinsky R; McNeely MC
Lancet; 1988 Jan; 1(8577):76-81. PubMed ID: 2891981
[TBL] [Abstract][Full Text] [Related]
7. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
Reddy MM; McKinley G; Englard A; Grieco MH
J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
Meng TC; Fischl MA; Boota AM; Spector SA; Bennett D; Bassiakos Y; Lai SH; Wright B; Richman DD
Ann Intern Med; 1992 Jan; 116(1):13-20. PubMed ID: 1345755
[TBL] [Abstract][Full Text] [Related]
9. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD
J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
Jackson GG; Paul DA; Falk LA; Rubenis M; Despotes JC; Mack D; Knigge M; Emeson EE
Ann Intern Med; 1988 Feb; 108(2):175-80. PubMed ID: 3124680
[TBL] [Abstract][Full Text] [Related]
11. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
Stambuk D; Hawkins D; Gazzard BG
J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
[TBL] [Abstract][Full Text] [Related]
14. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.
Rinaldo C; Kingsley L; Neumann J; Reed D; Gupta P; Lyter D
J Clin Microbiol; 1989 May; 27(5):880-4. PubMed ID: 2501352
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center.
Valentine FT; Seidlin M; Hochster H; Laverty M
Rev Infect Dis; 1990; 12 Suppl 5():S534-9. PubMed ID: 1974725
[TBL] [Abstract][Full Text] [Related]
16. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF
Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279
[TBL] [Abstract][Full Text] [Related]
18. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.
Cooley TP; Kunches LM; Saunders CA; Ritter JK; Perkins CJ; McLaren C; McCaffrey RP; Liebman HA
N Engl J Med; 1990 May; 322(19):1340-5. PubMed ID: 2139174
[TBL] [Abstract][Full Text] [Related]
19. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
Meng TC; Fischl MA; Richman DD
Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
[TBL] [Abstract][Full Text] [Related]
20. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
Larder BA; Darby G; Richman DD
Science; 1989 Mar; 243(4899):1731-4. PubMed ID: 2467383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
